Left ventricular T2 distribution in Duchenne Muscular Dystrophy

Journal of Cardiovascular Magnetic Resonance

Volumn 12, Issue 1, 2010, Pages

  Wansapura, Janaka P ^a   Hor, Kan N ^a   Mazur, Wojciech ^b   Fleck, Robert ^a   Hagenbuch, Sean ^a   Benson, D Woodrow ^a   Gottliebson, William M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CHRIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CARDIOMYOPATHY; CASE CONTROL STUDY; CHILD; CROSS-SECTIONAL STUDY; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGE FACTORS; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, DUCHENNE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 77952529797     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-12-14     Document Type: Article

References (34)

1. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. H Moser, Hum Genet 1984 66 17 40 10.1007/BF00275183 6365739
2. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. E Bonilla CE Samitt AF Miranda AP Hays G Salviati S DiMauro LM Kunkel EP Hoffman LP Rowland, Cell 1988 54 447 452 10.1016/0092-8674(88)90065-7 3042151
3. The cardiomyopathy of progressive muscular dystrophy. JK Perloff AC de Leon Jr D O'Doherty, Circulation 1966 33 625 648 5937560
4. Bcl-2 overexpression prevents calcium overload and subsequent apoptosis in dystrophic myotubes. O Basset FX Boittin C Cognard B Constantin UT Ruegg, Biochem J 2006 395 267 276 10.1042/BJ20051265 16393138
5. New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD. B Constantin S Sebille C Cognard, J Muscle Res Cell Motil 2006 27 375 386 10.1007/s10974-006-9085-2 16897576
6. Pathophysiology of duchenne muscular dystrophy: current hypotheses. N Deconinck B Dan, Pediatr Neurol 2007 36 1 7 10.1016/j.pediatrneurol.2006.09.016 17162189
7. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. MC Silva ZM Meira J Gurgel Giannetti MM da Silva AF Campos M Barbosa Mde GM Starling Filho A Ferreira Rde M Zatz CE Rochitte, J Am Coll Cardiol 2007 49 1874 1879 10.1016/j.jacc.2006.10.078 17481447
8. Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging. MW Ashford Jr W Liu SJ Lin P Abraszewski SD Caruthers AM Connolly X Yu SA Wickline, Circulation 2005 112 2462 2467 10.1161/CIRCULATIONAHA.104.516716 16216964
9. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. KN Hor J Wansapura LW Markham W Mazur LH Cripe R Fleck DW Benson WM Gottliebson, J Am Coll Cardiol 2009 53 1204 1210 10.1016/j.jacc.2008.12.032 19341862
10. A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic? PA Bottomley CJ Hardy RE Argersinger G Allen-Moore, Med Phys 1987 14 1 37 10.1118/1.596111 3031439
11. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. PA Bottomley TH Foster RE Argersinger LM Pfeifer, Med Phys 1984 11 425 448 10.1118/1.595535 6482839
12. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. Y Huang S Majumdar HK Genant WP Chan KR Sharma P Yu M Mynhier RG Miller, J Magn Reson Imaging 1994 4 59 64 10.1002/jmri.1880040113 8148557
13. Estimation of myocardial water content using transverse relaxation time from dual spin-echo magnetic resonance imaging. LM Boxt D Hsu J Katz P Detweiler S McLaughlin TJ Kolb HM Spotnitz, Magn Reson Imaging 1993 11 375 383 10.1016/0730-725X(93)90070-T 8505871
14. Dependence of the spin-spin relaxation time of water in collagen gels on collagen fiber directions. M Takeuchi M Sekino N Iriguchi S Ueno, Magn Reson Med Sci 2004 3 153 157 10.2463/mrms.3.153 16093633
15. Investigation of T2-weighted signal intensity of infarcted myocardium and its correlation with delayed enhancement magnetic resonance imaging in a porcine model with reperfused acute myocardial infarction. SH Choi JW Kang ST Kim BH Lee EJ Chun KH Schuleri SI Choi TH Lim, Int J Cardiovasc Imaging 2009 25 Suppl 1 111 119 10.1007/s10554-009-9425-6 19184523
16. Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. RC Cury K Shash JT Nagurney G Rosito MD Shapiro CH Nomura S Abbara F Bamberg M Ferencik EJ Schmidt DF Brown U Hoffmann TJ Brady, Circulation 2008 118 837 844 10.1161/CIRCULATIONAHA.107.740597 18678772
17. Value of T2-weighted, first-pass and delayed enhancement, and cine CMR to differentiate between acute and chronic myocardial infarction. A Stork K Muellerleile PM Bansmann J Graessner M Kaul J Kemper G Adam GK Lund, Eur Radiol 2007 17 610 617 10.1007/s00330-006-0460-6 17149626
18. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. A Zagrosek H Abdel-Aty P Boye R Wassmuth D Messroghli W Utz A Rudolph S Bohl R Dietz J Schulz-Menger, JACC Cardiovasc Imaging 2009 2 131 138 10.1016/j.jcmg.2008.09.014 19356545
19. Intensification of relative myocardial T2-weighted magnetic resonance signals in patients with acute viral myocarditis: report of one case. CT Shen CM Jeng YM Lin PU Chieng, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1993 34 405 411 8237361
20. Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. PY Marie JP Carteaux JM Escanye O Claudon N David S Mattei N Hassan N Danchin G Karcher A Bertrand JP Villemot, J Heart Lung Transplant 2001 20 193 194 10.1016/S1053-2498(00)00406-X 11250334
21. Cardiac and sternocleidomastoid muscle involvement in Duchenne muscular dystrophy: an MRI study. S Mavrogeni GE Tzelepis G Athanasopoulos T Maounis M Douskou A Papavasiliou DV Cokkinos, Chest 2005 127 143 148 10.1378/chest.127.1. 143 15653975
22. Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study. S Mavrogeni A Papavasiliou M Douskou G Kolovou E Papadopoulou DV Cokkinos, Eur J Paediatr Neurol 2009 13 34 40 10.1016/j.ejpn.2008.02.006 18406648
23. Increased susceptibility of the left lateral free wall to myocardial delayed enhancement in Duchenne Muscular Dystrophy: progressive systolic dysfunction demonstrable by CMR regional strain analysis. N Kissoon KN Hor JP Wansapura W Mazur RJ Fleck MD Puchalski DW Benson WM Gottliebson, Journal of Cardiovascular Magnetic Resonance 2009 11 12 10.1186/1532-429X-11-S1-P12
24. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? MD Puchalski RV Williams B Askovich CT Sower KH Hor JT Su N Pack E Dibella WM Gottliebson, Int J Cardiovasc Imaging 2009 25 57 63 10.1007/s10554-008-9352-y 18686011
25. Characterization of alterations in diabetic myocardial tissue using high resolution MRI. R Loganathan M Bilgen B Al-Hafez IV Smirnova, Int J Cardiovasc Imaging 2006 22 81 90 10.1007/s10554-005-5386-6 16362172
26. Thallium-201 single photon emission computed tomography (SPECT) in patients with duchenne's progressive muscular dystrophy: a histopathologic correlation study. T Nishimura A Yanagisawa H Sakata K Sakata K Shimoyama T Ishihara H Yoshino K Ishikawa, Jpn Circ J 2001 65 99 105 10.1253/jcj.65.99 11216833
27. Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience. C Silva JC Moon AG Elkington AS John RH Mohiaddin DJ Pennell, J Cardiovasc Med (Hagerstown) 2007 8 1076 1079 18163027
28. Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy. A Varghese DJ Pennell, Heart 2004 90 59 10.1136/hrt.2004. 041277 15310728
29. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. A Yilmaz HJ Gdynia H Baccouche H Mahrholdt G Meinhardt C Basso G Thiene AD Sperfeld AC Ludolph U Sechtem, J Cardiovasc Magn Reson 2008 10 50 10.1186/1532-429X-10-50 18983659
30. T2 quantification for improved detection of myocardial edema. S Giri YC Chung A Merchant G Mihai S Rajagopalan SV Raman OP Simonetti, J Cardiovasc Magn Reson 2009 11 56 10.1186/1532-429X-11-56 20042111
31. Adiabatic refocusing pulse which compensates for variable rf power and off-resonance effects. MR Bendall M Garwood K Ugurbil DT Pegg, Magn Reson Med 1987 4 493 499 10.1002/mrm.1910040510 3600255
32. Magnetic resonance imaging with adiabatic pulses using a single surface coil for RF transmission and signal detection. M Garwood K Ugurbil AR Rath MR Bendall BD Ross SL Mitchell H Merkle, Magn Reson Med 1989 9 25 34 10.1002/mrm.1910090105 2709994
33. Fast broadband inversion by adiabatic pulses. TL Hwang PC van Zijl M Garwood, J Magn Reson 1998 133 200 203 10.1006/jmre.1998.1441 9654487
34. T2 relaxometry of the hippocampus at 3T. PA Bartlett MR Symms SL Free JS Duncan, AJNR Am J Neuroradiol 2007 28 1095 1098 10.3174/ajnr.A0505 17569966